MGI PHARMA, INC. is an oncology and acute care focused biopharmaceutical company that acquires, researches, develops and commercializes proprietary products that address the unmet needs of patients. MGI PHARMA has a portfolio of proprietary pharmaceuticals, and intends to become a leader in oncology and acute care. MGI PHARMA markets Aloxi® (palonosetron hydrochloride) Injection, Dacogen® (decitabine) for Injection and Gliadel® (polifeprosan 20 with carmustine implant) Wafer in the United States. The Company directly markets its products in the U.S. and collaborates with partners to reach international markets.

At MGI PHARMA, INC. our vision of becoming a leader in oncology and acute care and our belief that our work has a positive impact on the lives of many creates an atmosphere of excitement and motivation that is reflected in all areas of the company. We believe that every associate can play an important role in making the MGI PHARMA vision a reality and strive to create a balanced culture that encourages and rewards both teamwork and individual growth.

Career Opportunities

View MGI PHARMA Jobs click here